In addition to PPARγ, other receptors including the related PPARβ/δ and estrogen-related receptor α, and signaling involving VEGF are also known to increase the metastatic potential of cancer (Carbonetti et al., 2019) (Table 2). Here, PPARD is linked to cancer.